Advertisement

International Journal of Clinical Oncology

, Volume 22, Issue 5, pp 964–971 | Cite as

A critical prognostic analysis of neutrophil–lymphocyte ratio for patients undergoing nephroureterectomy due to upper urinary tract urothelial carcinoma

  • Mesut Altan
  • Hakan Bahadır HaberalEmail author
  • Bülent Akdoğan
  • Haluk Özen
Original Article

Abstract

Background

To determine preoperative serum complete blood count parameters that affects survival of patients who underwent surgery for upper urinary tract urothelial cancer (UUT-UC).

Methods

Since 1990, 150 patients underwent nephroureterectomy with bladder cuff excision for UUT-UC at Hacettepe University. Patients with a history of muscle-invasive bladder cancer, adjuvant chemotherapy or metastasis at the time of diagnosis were excluded. One hundred and thirteen patients without infective symptoms and with a full set of serum data were evaluated retrospectively. Effects of the neutrophil–lymphocyte ratio (NLR), lymphocyte–monocyte ratio (LMR), platelet–lymphocyte ratio (PLR), and leukocyte count on disease-free survival (DFS) and progression-free survival (PFS) were investigated. Threshold values for each parameter to predict PFS were calculated.

Results

The mean age and median follow-up were 63.7 ± 11.1 years and 34 (3–186) months, respectively. Male to female ratio was 86/27. The 5-years PFS (bladder recurrence was excluded) and DFS were 59.6 and 38.4%, respectively. In multivariate analysis, NLR was independent prognostic factor for PFS and DFS (p = 0.006 and p = 0.021, respectively) while LMR was prognostic only for PFS (p = 0.037).

Conclusion

For UUT-UC, NLR is a prognostic factor for PFS and DFS, while LMR is a prognostic indicator for PFS in present series.

Keywords

Upper urinary tract Urothelial carcinoma Neutrophil–lymphocyte ratio Complete blood count parameters Progression free survival 

Notes

Compliance with ethical standards

Conflict of interest

The author declares that they have no conflict on interest

References

  1. 1.
    Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62(1):10–29CrossRefPubMedGoogle Scholar
  2. 2.
    David KA, Mallin K, Milowsky MI et al (2009) Surveillance of urothelial carcinoma: stage and grade migration, 1993–2005 and survival trends, 1993–2000. Cancer 115(7):1435–1447CrossRefPubMedGoogle Scholar
  3. 3.
    Margulis V, Shariat SF, Matin SF et al (2009) Outcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration. Cancer 115(6):1224–1233CrossRefPubMedGoogle Scholar
  4. 4.
    Fajkovic H, Cha EK, Xylinas E et al (2013) Disease-free survival as a surrogate for overall survival in upper tract urothelial carcinoma. World J Urol 31(1):5–11CrossRefPubMedGoogle Scholar
  5. 5.
    Kobayashi K, Saito T, Kitamura Y et al (2016) Effect of preoperative chemotherapy on survival of patients with upper urinary tract urothelial carcinoma clinically involving regional lymph nodes. Int J Urol 23(2):153–158CrossRefPubMedGoogle Scholar
  6. 6.
    Porten S, Siefker-Radtke AO, Xiao L et al (2014) Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma. Cancer 120(12):1794–1799CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Lughezzani G, Burger M, Margulis V et al (2012) Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. Eur Urol 62(1):100–114CrossRefPubMedGoogle Scholar
  8. 8.
    Margulis V, Youssef RF, Karakiewicz PI et al (2010) Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract. J Urol 184(2):453–458CrossRefPubMedGoogle Scholar
  9. 9.
    Mantovani A, Allavena P, Sica A et al (2008) Cancer-related inflammation. Nature 454(7203):436–444CrossRefPubMedGoogle Scholar
  10. 10.
    Deng Y, Pang Q, Miao RC et al (2016) Prognostic significance of pretreatment albumin/globulin ratio in patients with hepatocellular carcinoma. Onco Targets Ther 9:5317–5328CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Sung HH, Jeon HG, Jeong BC et al (2015) Clinical significance of prognosis using the neutrophil-lymphocyte ratio and erythrocyte sedimentation rate in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma. BJU Int 115(4):587–594CrossRefPubMedGoogle Scholar
  12. 12.
    Azuma T, Matayoshi Y, Odani K et al (2013) Preoperative neutrophil-lymphocyte ratio as an independent prognostic marker for patients with upper urinary tract urothelial carcinoma. Clin Genitourin Cancer 11(3):337–341CrossRefPubMedGoogle Scholar
  13. 13.
    Dalpiaz O, Ehrlich GC, Mannweiler S et al (2014) Validation of pretreatment neutrophil–lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma. BJU Int 114(3):334–339PubMedGoogle Scholar
  14. 14.
    Cappellini MD, Motta I (2015) Anemia in clinical practice-definition and classification: does hemoglobin change with aging? Semin Hematol 52(4):261–269CrossRefPubMedGoogle Scholar
  15. 15.
    Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57–70CrossRefPubMedGoogle Scholar
  16. 16.
    Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674CrossRefPubMedGoogle Scholar
  17. 17.
    Gabrilovich DI, Nagaraj S (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9(3):162–174CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Kusumanto YH, Dam WA, Hospers GA et al (2003) Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis 6(4):283–287CrossRefPubMedGoogle Scholar
  19. 19.
    Azab B, Bhatt VR, Phookan J et al (2012) Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients. Ann Surg Oncol 19(1):217–224CrossRefPubMedGoogle Scholar
  20. 20.
    Ding PR, An X, Zhang RX et al (2010) Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer. Int J Colorectal Dis 25(12):1427–1433CrossRefPubMedGoogle Scholar
  21. 21.
    Pages F, Berger A, Camus M et al (2005) Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 353(25):2654–2666CrossRefPubMedGoogle Scholar
  22. 22.
    Fujita K, Uemura M, Yamamoto Y et al (2015) Preoperative risk stratification for cancer-specific survival of patients with upper urinary tract urothelial carcinoma treated by nephroureterectomy. Int J Clin Oncol 20(1):156–163CrossRefPubMedGoogle Scholar
  23. 23.
    McMillan DC (2013) The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev 39(5):534–540CrossRefPubMedGoogle Scholar
  24. 24.
    Tanaka N, Kikuchi E, Kanao K et al (2014) A multi-institutional validation of the prognostic value of the neutrophil-to-lymphocyte ratio for upper tract urothelial carcinoma treated with radical nephroureterectomy. Ann Surg Oncol 21(12):4041–4048CrossRefPubMedGoogle Scholar
  25. 25.
    Cheng YC, Huang CN, Wu WJ et al (2016) The prognostic significance of inflammation-associated blood cell markers in patients with upper tract urothelial carcinoma. Ann Surg Oncol 23(1):343–351CrossRefPubMedGoogle Scholar
  26. 26.
    Sparr KE, Balcom AH, Mesrobian HG (1998) Incidence and natural history of contralateral vesicoureteral reflux in patients presenting with unilateral disease. J Urol 160(3 Pt 2):1023–1025CrossRefPubMedGoogle Scholar
  27. 27.
    Chen Q, Dai Z, Yin D et al (2015) Negative impact of preoperative platelet-lymphocyte ratio on outcome after hepatic resection for intrahepatic cholangiocarcinoma. Medicine 94(13):e574CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Hutterer GC, Stoeckigt C, Stojakovic T et al (2014) Low preoperative lymphocyte-monocyte ratio (LMR) represents a potentially poor prognostic factor in nonmetastatic clear cell renal cell carcinoma. Urol Oncol 32(7):1041–1048CrossRefPubMedGoogle Scholar
  29. 29.
    Song X, Zhang GM, Ma XC et al (2016) Comparison of preoperative neutrophil-lymphocyte, lymphocyte-monocyte, and platelet-lymphocyte ratios in patients with upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy. Onco Targets Ther 9:1399–1407CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Kaag M, Trost L, Thompson RH et al (2014) Preoperative predictors of renal function decline after radical nephroureterectomy for upper tract urothelial carcinoma. BJU Int 114(5):674–679CrossRefPubMedGoogle Scholar
  31. 31.
    Xylinas E, Rink M, Margulis V et al (2013) Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy. BJU Int 112(4):453–461CrossRefPubMedGoogle Scholar

Copyright information

© Japan Society of Clinical Oncology 2017

Authors and Affiliations

  1. 1.Department of UrologyHacettepe University School of MedicineAnkaraTurkey

Personalised recommendations